Cohort and Community Surveillance Components

Slides:

Advertisements

Similar presentations

| 1| 1Peer Report: Dialysis Care & Outcomes in the U.S., 2014 | Hospitalization Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Hospitalization.

Advertisements

UKPDS Paper 35 Slides © University of Oxford Diabetes Trials Unit

Surveillance of Heart Diseases and Stroke Using Centers for Medicare and Medicaid (CMS) Data: A Researcher’s Perspective Judith H. Lichtman, PhD MPH Associate.

Gerard Dou, The Dropsical Woman, 1663, Louvre, Paris Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Executive Summary.

| 1| 1Peer Report: Dialysis Care & Outcomes in the U.S., 2014 | Incidence Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Incidence.

National Report Card on Hospital care for heart disease in Indigenous Australia Traven Lea, National Manager, Aboriginal and Torres Strait Islander Program.

Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.

Slide Source: Lipids Online Slide Library Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.

Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.

Aquiring the Evidence TEACH 2013 TRACK 1.  Therapy  Utility  Performance  Likelihood  Diagnosis  Utility  Performance  Likelihood  Prognosis.

Clinical Outcomes with Newer Antihyperglycemic Agents

Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:

1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.

Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.

Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:

The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT Systolic Heart failure.

Diabetes Mellitus 101 for Cardiologists (and Alike): 2015

Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,

Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.

ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)

Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.

1 Pre-Specified Outcomes All primary and secondary outcomes and their components were pre-specified, i.e., they appeared in the protocol, manual of operations.

Clinical Outcomes with Newer Antihyperglycemic Agents FDA-Mandated CV Safety Trials 1.

Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]

6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.

Charmaine J. Palafox, MD. Approx. 50% of CHD deaths occurs as sudden cardiac arrest.

R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.

Overview of Diagnosed and Undiagnosed Diabetes in the United States— American Diabetes Association. Diabetes Care. 2008;31: American Diabetes.

Discontinuation of medication after nonfatal event: MI

Nephrology Journal Club The SPRINT Trial Parker Gregg

Ratio of percentile groups

Clinical need for determination of vulnerable plaques

Copyright © 2015 by the American Osteopathic Association.

Copyright © 2006 American Medical Association. All rights reserved.

TNT: Baseline and final LDL cholesterol levels

Select Topics in Cardiovascular Medicine

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Heart Failure Management Coordinated Care Approaches

A. Heart failure: A challenge to the healthcare delivery system

Heart Failure Prevention: Mission Impossible?

Should SGLT2 Inhibitors Be the Primary Agents for CV Risk Reduction in T2DM?

INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.

OptiLink HF Trial design: Patients with heart failure who underwent implantation of an ICD were randomized to telemonitoring (n = 505) vs. usual care (n.

Rounded incidence values (%) of renal and nonrenal events

Expert Insights on Complex Clinical Cases of Edema

VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =

The Heart Failure Team Heart Failure Care Map First 24 hours.

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

CV Risk Management in T2DM: What Did We Learn from ADA 2016?

Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

Toby L. Merlin, M.D. Deputy Incident Manager CDC H1N1 Response

Nat. Rev. Cardiol. doi: /nrcardio

Post-Heart Failure Mortality

Total Outpatient Visits

Baseline Characteristics by Baseline N-BNP Level

Cause of death Treatment-arm events, % (n=45 054)

2015 EASD In Review: CV Risk management in t2dm

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Our Community Where is …?.

Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

FIELD: Primary outcome

Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Outcomes Group Number of events Total person-years aIRR (95%CI)

Outcomes Number of events† Total person-years† aHR‡ (95%CI)

Outcomes Number of events† Total person-years† aHR‡ (95%CI)

One-year cumulative incidence rates of adverse clinical outcomes in 9,428 outpatients with CHF stratified by diabetes status at baseline. One-year cumulative.

Presentation transcript:

Cohort and Community Surveillance Components 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 Exam 1 n=15,792 Exam 2 n=14,348 Exam 3 n=12,887 Exam 4 n=11,656 Exam 5 n=6,538 Exam 6 n= 4,214 Exam 7 n~ 3,700 CY2 CY 5 CY 8 CY 11 CY 14 CY 17 CY20 CY 23 CY 26 CY 29 CY 3 CY 6 CY 9 CY 12 CY 15 CY 18 CY 21 CY 24 CY 27 CY 30 CY 4 CY 7 CY 10 CY 13 CY 16 CY 19 CY 22 CY 25 CY 28 CY 31 Cohort Exams Annual Follow-Up (Contact Years) Surveillance Outcomes Incident MI Incident Stroke Sudden Death C O H O R T Incident Decompensated HF Incident Chronic Stable HF Outpatient HF Incident Hospital Heart Failure (Not Validated) 1987 2005 2014 2015 2017 2019 CHD Incidence CHD Mortality CHD Case Fatality Hospital Heart Failure (Not Validated) Decompensated HF Incidence Chronic Stable HF Incidence HF Medical Care Outpatient HF (Medicare Data) EHR Events EHR Pilot C O M M U N I T Y HF Case Fatality